Familial Hypercholesterolemia and Acute Coronary Syndromes: The Microbiota–Immunity Axis in the New Diagnostic and Prognostic Frontiers

Familial hypercholesterolemia is a common genetic disorder with a propensity towards early onset of atherosclerotic cardiovascular disease (CVD). The main goal of therapy is to reduce the LDL cholesterol and the current treatment generally consists of statin, ezetimibe and PCSK9 inhibitors. Unfortun...

Descripción completa

Detalles Bibliográficos
Autores principales: Piccioni, Andrea, Niccolai, Elena, Rozzi, Gloria, Spaziani, Giacomo, Zanza, Christian, Candelli, Marcello, Covino, Marcello, Gasbarrini, Antonio, Franceschi, Francesco, Amedei, Amedeo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142551/
https://www.ncbi.nlm.nih.gov/pubmed/37111513
http://dx.doi.org/10.3390/pathogens12040627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142551/
https://www.ncbi.nlm.nih.gov/pubmed/37111513
http://dx.doi.org/10.3390/pathogens12040627

Ejemplares similares